BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 15471223)

  • 1. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
    Tomer A
    J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombogenesis in sickle cell disease.
    Tomer A; Harker LA; Kasey S; Eckman JR
    J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
    J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPV is a marker of in vivo platelet activation--study in a rat thrombosis model.
    Ravanat C; Freund M; Mangin P; Azorsa DO; Schwartz C; Moog S; Schuhler S; Dambach J; Cazenave JP; Lanza F
    Thromb Haemost; 2000 Feb; 83(2):327-33. PubMed ID: 10739394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation.
    Vidal C; Spaulding C; Picard F; Schaison F; Melle J; Weber S; Fontenay-Roupie M
    Thromb Haemost; 2001 Sep; 86(3):784-90. PubMed ID: 11583308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
    Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
    Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of platelet function by flow cytometry.
    Michelson AD; Barnard MR; Krueger LA; Frelinger AL; Furman MI
    Methods; 2000 Jul; 21(3):259-70. PubMed ID: 10873480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
    Tomer A; Kasey S; Connor WE; Clark S; Harker LA; Eckman JR
    Thromb Haemost; 2001 Jun; 85(6):966-74. PubMed ID: 11434703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet hyporeactivity in very low birth weight neonates.
    Rajasekhar D; Barnard MR; Bednarek FJ; Michelson AD
    Thromb Haemost; 1997 May; 77(5):1002-7. PubMed ID: 9184418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometric 3-color analysis of circulating activated platelets and its clinical significance in ischemic cerebrovascular diseases].
    Wang J; Cao L; He M
    Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):499-502. PubMed ID: 11798806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet surface P-selectin molecules increased after exposing platelet to a high shear flow.
    Goto S; Ichikawa N; Lee M; Goto M; Sakai H; Kim JJ; Yoshida M; Handa M; Ikeda Y; Handa S
    Int Angiol; 2000 Jun; 19(2):147-51. PubMed ID: 10905798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot study.
    Neumeister P; Hiller E; Gawaz M; Holler E; Kolb HJ; Sill H; Pihusch R; Mempel W; Wittmann G; Salat C
    Eur J Med Res; 1998 Oct; 3(10):465-9. PubMed ID: 9753703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of surface membrane proteins on activated platelets and platelet-derived microparticles from healthy and thrombasthenic individuals.
    Nomura S; Komiyama Y; Murakami T; Funatsu A; Kokawa T; Sugo T; Matsuda M; Yasunaga K
    Int J Hematol; 1993 Oct; 58(3):203-12. PubMed ID: 8148498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a whole platelet ELISA to detect circulating activated platelets.
    Amrani DL; Stojanovic L; Mosesson MN; Shalev Y; Mosesson MW
    J Lab Clin Med; 1995 Dec; 126(6):603-11. PubMed ID: 7490520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against platelet membrane glycoproteins IIb/IIIa and Ibalpha inhibit platelet dependent thrombin generation by different mechanisms.
    Thomas S; Metcalfe P; Goodall AH; Gray E
    Thromb Haemost; 2000 Jul; 84(1):98-103. PubMed ID: 10928478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity.
    Dicker IB; Pedicord DL; Seiffert DA; Jamieson GA; Greco NJ
    Thromb Haemost; 2001 Oct; 86(4):1065-9. PubMed ID: 11686325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous engagement of thrombin and Fc gamma RIIA receptors results in platelets expressing high levels of procoagulant proteins.
    Batar P; Dale GL
    J Lab Clin Med; 2001 Dec; 138(6):393-402. PubMed ID: 11753286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation and thrombosis: studies in a patient with essential thrombocythemia.
    Nurden P; Bihour C; Smith M; Raymond JM; Nurden AT
    Am J Hematol; 1996 Jan; 51(1):79-84. PubMed ID: 8571943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression patterns of platelet membrane glycoprotein in healthy adults].
    Huang F; Liu R; Liu L
    Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):465-7. PubMed ID: 11721409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated platelet-derived microparticle levels during unstable angina.
    Singh N; Gemmell CH; Daly PA; Yeo EL
    Can J Cardiol; 1995 Dec; 11(11):1015-21. PubMed ID: 8542543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.